HK Stock MarketDetailed Quotes

02415 MEDSCI

Watchlist
  • 0.660
  • +0.030+4.76%
Market Closed Sep 13 16:08 CST
400.73MMarket Cap8.46P/E (TTM)

MEDSCI Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
-26.91%110.67M
0.07%349.19M
--151.4M
17.20%348.95M
37.93%297.73M
30.51%215.85M
--165.39M
Operating income
-26.91%110.67M
0.07%349.19M
151.4M
17.20%348.95M
37.93%297.73M
30.51%215.85M
165.39M
Cost of sales
32.25%-42.73M
7.04%-132.59M
---63.07M
-32.16%-142.63M
-9.21%-107.92M
-42.24%-98.82M
---69.48M
Operating expenses
32.25%-42.73M
7.04%-132.59M
-63.07M
-32.16%-142.63M
-9.21%-107.92M
-42.24%-98.82M
-69.48M
Gross profit
-23.09%67.94M
4.99%216.61M
88.33M
8.70%206.32M
62.19%189.81M
22.02%117.03M
95.91M
Selling expenses
23.88%-37.85M
4.65%-90.49M
---49.73M
-14.04%-94.9M
-78.63%-83.22M
-22.60%-46.59M
---38M
Administrative expenses
-12.74%-35.82M
23.15%-56.4M
---31.77M
-85.24%-73.39M
-77.52%-39.62M
-5.91%-22.32M
---21.07M
Research and development expenses
37.20%-12.02M
-13.83%-39.86M
---19.14M
-43.43%-35.01M
-35.04%-24.41M
9.24%-18.08M
---19.92M
Revaluation surplus
----
111.69%12.79M
--12.79M
42.64%-109.35M
---190.63M
----
----
-Changes in the fair value of other assets
----
111.69%12.79M
--12.79M
42.64%-109.35M
---190.63M
----
----
Impairment and provision
9.27%-519K
-437.33%-13.62M
---572K
61.04%-2.53M
-1,182.84%-6.5M
-71.86%-507K
---295K
-Other impairment is provision
9.27%-519K
-437.33%-13.62M
---572K
61.04%-2.53M
-1,182.84%-6.5M
-71.86%-507K
---295K
Special items of operating profit
37.92%18.12M
145.10%31.7M
--13.14M
66.14%12.93M
92.13%7.79M
58.96%4.05M
--2.55M
Operating profit
-101.17%-152K
163.30%60.73M
13.04M
34.64%-95.94M
-536.94%-146.79M
75.17%33.59M
19.18M
Financing cost
42.48%-88K
22.69%-276K
---153K
-31.73%-357K
35.63%-271K
7.47%-421K
---455K
Earning before tax
-101.86%-240K
162.78%60.45M
12.89M
34.52%-96.29M
-543.31%-147.06M
77.18%33.17M
18.72M
Tax
150.41%488K
-50.68%-5.41M
---968K
9.64%-3.59M
6.74%-3.97M
-149.65%-4.26M
---1.71M
After-tax profit from continuing operations
-97.92%248K
155.11%55.04M
11.92M
33.87%-99.88M
-622.34%-151.03M
69.91%28.91M
17.02M
Earning after tax
-97.92%248K
155.11%55.04M
11.92M
33.87%-99.88M
-622.34%-151.03M
69.91%28.91M
17.02M
Profit attributable to shareholders
-97.92%248K
155.11%55.04M
11.92M
33.87%-99.88M
-622.34%-151.03M
69.91%28.91M
17.02M
Basic earnings per share
-97.92%0.0005
152.38%0.11
0.024
98.81%-0.21
-682.18%-17.64
72.16%3.03
1.76
Diluted earnings per share
129.41%0.0005
138.10%0.08
-0.0017
98.81%-0.21
-682.18%-17.64
72.16%3.03
1.76
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover -26.91%110.67M0.07%349.19M--151.4M17.20%348.95M37.93%297.73M30.51%215.85M--165.39M
Operating income -26.91%110.67M0.07%349.19M151.4M17.20%348.95M37.93%297.73M30.51%215.85M165.39M
Cost of sales 32.25%-42.73M7.04%-132.59M---63.07M-32.16%-142.63M-9.21%-107.92M-42.24%-98.82M---69.48M
Operating expenses 32.25%-42.73M7.04%-132.59M-63.07M-32.16%-142.63M-9.21%-107.92M-42.24%-98.82M-69.48M
Gross profit -23.09%67.94M4.99%216.61M88.33M8.70%206.32M62.19%189.81M22.02%117.03M95.91M
Selling expenses 23.88%-37.85M4.65%-90.49M---49.73M-14.04%-94.9M-78.63%-83.22M-22.60%-46.59M---38M
Administrative expenses -12.74%-35.82M23.15%-56.4M---31.77M-85.24%-73.39M-77.52%-39.62M-5.91%-22.32M---21.07M
Research and development expenses 37.20%-12.02M-13.83%-39.86M---19.14M-43.43%-35.01M-35.04%-24.41M9.24%-18.08M---19.92M
Revaluation surplus ----111.69%12.79M--12.79M42.64%-109.35M---190.63M--------
-Changes in the fair value of other assets ----111.69%12.79M--12.79M42.64%-109.35M---190.63M--------
Impairment and provision 9.27%-519K-437.33%-13.62M---572K61.04%-2.53M-1,182.84%-6.5M-71.86%-507K---295K
-Other impairment is provision 9.27%-519K-437.33%-13.62M---572K61.04%-2.53M-1,182.84%-6.5M-71.86%-507K---295K
Special items of operating profit 37.92%18.12M145.10%31.7M--13.14M66.14%12.93M92.13%7.79M58.96%4.05M--2.55M
Operating profit -101.17%-152K163.30%60.73M13.04M34.64%-95.94M-536.94%-146.79M75.17%33.59M19.18M
Financing cost 42.48%-88K22.69%-276K---153K-31.73%-357K35.63%-271K7.47%-421K---455K
Earning before tax -101.86%-240K162.78%60.45M12.89M34.52%-96.29M-543.31%-147.06M77.18%33.17M18.72M
Tax 150.41%488K-50.68%-5.41M---968K9.64%-3.59M6.74%-3.97M-149.65%-4.26M---1.71M
After-tax profit from continuing operations -97.92%248K155.11%55.04M11.92M33.87%-99.88M-622.34%-151.03M69.91%28.91M17.02M
Earning after tax -97.92%248K155.11%55.04M11.92M33.87%-99.88M-622.34%-151.03M69.91%28.91M17.02M
Profit attributable to shareholders -97.92%248K155.11%55.04M11.92M33.87%-99.88M-622.34%-151.03M69.91%28.91M17.02M
Basic earnings per share -97.92%0.0005152.38%0.110.02498.81%-0.21-682.18%-17.6472.16%3.031.76
Diluted earnings per share 129.41%0.0005138.10%0.08-0.001798.81%-0.21-682.18%-17.6472.16%3.031.76
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data